February 2013
Table of Contents
Funding Opportunities

Shared Resource Spotlight
Flow Cytometry Core
The FC Core provides
investigators with a wide 
range of services related to
cell sorting and analysis.

Coming soon! 
The FC Core will have an 
Amnis ImageStream Mark II. 
This system can produce
60,000 images of 10,000 
cells in about 30 seconds 
and 600,000 images of 
100,000 cells in just over 
5 minutes. The system utilizes the IDEAS® data analysis software that currently calculates over
40 quantitative features per image, resulting in approx. 250 features per cell. 
These features can be used to generate histograms and 
scatter plots, much like 
standard FC analysis software. Learn more about the Amnis ImageStream
Daniel Conrad, Ph.D., 
and Julie Farnsworth
Contact Information: 
(804) 828-2311

View more information
about the FC Core.

Connect with us! 
Join Massey's online communities.

Like us on Facebook  Follow us on Twitter  View our videos on YouTube
Leaders' UpdateUpdate

A message from Harry Bear,
Interim associate director for clinical research

I am pleased to update you on clinical research at Massey. We've made progress on several fronts...

This message continues with more information about:
Research HighlightsHighlights
Cancer Cell Signaling
Multiple sclerosis drug may one day treat colorectal cancer
Fingolimod, a drug currently approved for the treatment of multiple sclerosis, has been found to potentially eliminate or reduce the progression of colorectal cancer.

Rakesh Kukreja, M.S., Ph.D.
Developmental Therapeutics
Viagra drug trio improves effectiveness of cancer treatment while protecting the heart

A new drug 'trifecta' combining doxorubicin, Viagra and rapamycin has been found to improve the effectiveness of cancer treatment while protecting the heart from harm caused by a popular form of chemotherapy. 

Lynne Penberthy, M.D., M.P.H.
Cancer Prevention and Control
Reasons patients are ineligible or refuse to participate in clinical trials
The reasons why Caucasian and African-American patients who are offered a clinical trial are ineligible or refuse to participate differ.

Center News Center1
Douglas R. Lowy, M.D.
Deputy director
National Cancer Institute

This year, the VCU Presidential Symposium led by Michael Rao, Ph.D., will focus on cancer. 

Dr. Rao has asked Massey to help develop the symposium.
Douglas R. Lowy, M.D., deputy director of the National Cancer Institute, will be the keynote speaker. 

Dr. Lowy's laboratory was involved in the initial development, characterization and clinical testing of preventive virus-like particles that are now used in two FDA-approved HPV vaccines. 

The symposium will likely occur in late September or October. Stay tuned for more information.
Member ShowcaseShowcase
Michael Miles, M.D., Ph.D.
Cancer and Molecular Genetics
Massey welcome
Michael MilesM.D., Ph.D., 
as one of the newest research members in the Cancer and Molecular Genetics program. 

Miles is also a professor of pharmacology and toxicology at the VCU School of Medicine. His cancer research focuses on understanding the molecular mechanisms of alcohol and tobacco addiction and how they modulate cancer risk.

Researcher RecognitionRecognition
Congratulations to the following Massey pilot grant award winners:
Congratulations as well to Jeffrey Williamson, Ph.D., for being named editor in chief of the journal Medical Physics.

Our Health Richmond
Boomer Magazine

Press coverage is compiled monthly for your convenience. 

 Share with us your research, awards and accomplishments! 
Submit your news to Alaina Farrish at akfarrish@vcu.edu or (804) 628-4578.